Netakimab (Anti-CTLA-8 / IL-17a)

Netakimab (Anti-CTLA-8 / IL-17a) is a humanized monoclonal antibody against interleukin-17 (IL-17) with the potential to treat moderate to severe plaque psoriasis. MW: 145.74 KD.
Supplier Selleck Chemicals
Product # A2863
Sku # A2863-1mg*5
Pricing 1mg*5, $1690.00
Feedback